In a 26-week henagliflozin trial, 90% of patients taking henagliflozin gained telomere length compared to 66% of patients receiving placebo
Agree
Disagree
Overview
Debates
Related claims
Topics
Best
Space b5a31f
Loading debates…
Opening sign-in…